Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?
Covering the life sciences inside and out
Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Adult human ovaries contain a population of stem cells capable of generating immature egg cells.
Funding only outstanding researchers is increasing the gap between good and great labs and forcing some out of science in search of a bigger paycheck.
Designing the simplest possible living organism artificially may lend clues as to what life is.
Researchers develop a tiny device that motors around the stomach, fueled by its acidic environment.
Two steps help Drosophila melanogaster larvae survive freezing conditions.
A new device can detect sounds a million times fainter than the hearing threshold of the human ear.
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
New research suggests that circular RNA transcripts are not as rare as previously thought.